Doctors finally receive clinical proof on a antioxidant supplement that slows down the progressive rate of aging. This new supplement ” Protandim” reduces Oxidative Stress by an average of 40 %. Oxidative Stress has been linked to over 200 diseases, such as Cancer, Diabetes, Alzheimer’s. Clinical blood tests of both men and women, young and old, show that after taking one caplet of Protandim daily for 30 days, test subjects realized a 40% average decrease in aging factors – dropping to the progressive aging rate of a 20 year old! When maintained for 120 days, Protandim® significantly increased activity of SOD and CAT antioxidant enzymes by 54%, substantially increasing the body’s antioxidant defenses to that of a newborn child. Click here to view the study.
There are presently studies being conducted in over 20 major universities on the impact of Protandim with Oxidative Stress, one of today’s hottest medical topics. Dr. Joe McCord is the scientist at the head of much of the data being compiled.
Protandim works differently than other antioxidant supplements. It actually signals the cells in our bodies to produce more of its own antioxidant enzymes, which provide thousands of times more antioxidant power than any food or conventional supplement.
An investigation into Protandim with boys with Duchenne Muscular Dystrophy (DMD) is particularly exciting, according to Dr. McCord. Parents of a number of boys with DMD tried Protandim with their sons and reported significant improvements in strength and endurance as well as cognitive function. DMD is one of over 100 human diseases associated with oxidative stress. DMD, by the way, is a genetic disease and impacts only males.
I share this with you because there is a growing body of evidence about Protandim and the incredible impact that it is having on so many aspects of our health issues. The earning potential for Protandim sales is quite significant given the data now being published. More studies are underway and when they are released, we will share that data with you.
Recognized scientist sees “very valuable” Protandim pass rigors of peer-review processes
Dr. Joe McCord, Ph.D.
I have spent forty years studying the antioxidant enzymes and their roles in normal physiology and in disease states. Most of this time was spent trying to find safe and effective ways to increase the activities of these enzymes to restore normal oxidative balance and to eliminate oxidative stress. Protandim offers the best solution so far, and it may be the best possible solution.
As a scientist, I feel the most exciting benefit provided by Protandim is knowing that I have eliminated the progressive, age-dependent increase in oxidative stress that accompanies aging. Scientists know that the so-called “diseases of aging” are closely associated with oxidative stress. This product has been completely validated by science. The five ingredients have been studied individually and in all possible combinations.
We understand in great detail how Protandim works to increase the cell’s production of its vital antioxidant enzymes, we can demonstrate the remarkable synergy achieved when these specific ingredients are combined, and we understand how these enzymes work together to decrease oxidative stress.
Each daily dose of Protandim sends signals to the DNA inside every cell. These signals turn on the “switches” that activate the genes that produce the family of antioxidant enzymes, causing more of these vital enzymes to be produced each day. When the signals stop coming, the genes return to their lower levels of production. Science advances when new tools come along, and Protandim is a very valuable new tool. It will allow us to explore the relationship between oxidative stress and the many diseases that seem so strongly associated with oxidative stress.
The peer-review process guarantees that published studies meet the rigorous standards that scientists impose upon themselves and each other. Each scientist relies on what others publish, so without the assurance of unbiased accuracy, rationale, and reproducibility, the system could not function. It would be nice if all aspects of our society had effective peer-reviewed processes. It is the quality assurance of the peer-review process that has attracted so many independent scientists at many other universities to study Protandim.
REAL SCIENCE BASED… NOT HYPE BASED
If you want the most reliable medical information, it is all at your disposal at the PubMed database website, provided by the National Library of Medicine. Just go to http://PubMed.gov and type in your search parameters. Type “Protandim” and hit Search and you will see all the peer-reviewed studies that have been published so far.
Two 2011 Peer Reviewed Studies
Protandim® found to prevent a process that causes blood vessel blockage in new peer-reviewed study from the Ohio State University. Protandim® prevents the proliferation of cells that can cause re-blockage of vessels following coronary artery bypass surgery, stenting, and carotid enarterectomy.
(CLICK HERE TO REACH PDF FILE)
Lifevantage’s Nrf2 activator reviewed for tumor prevention and suppression in new peer-reviewed article. Protandim’s ability to modulate mitochondrial superoxide dismutase and tumor suppressor p53 believed responsible. Article published in the scientific journal ENZYME RESEARCH.
(CLICK HERETO REACH PDF FILE)
Protandim® Found to Prevent a Process that Causes Blood Vessel Blockage in New Peer-Reviewed Study From The Ohio State University
Protandim prevents the proliferation of cells that can cause re-blockage of vessels following coronary artery bypass surgery, stenting, and carotid enarterectomy
A new peer-reviewed study involving Protandim, sponsored by the American Heart Association and the National Institutes of Health, was published in the scientific journal Free Radical Biology and Medicine. The study, conducted by researchers at The Ohio State University, examined the biochemical mechanisms that underlie the ability of Protandim to suppress intimal hyperplasia (over-proliferation of cells that line the vessel wall), a common adverse event that limits the effectiveness of several types of vascular surgery. Protandim has been shown in earlier studies to activate the transcription factor Nrf2, a signal to the cell’s DNA to regulate a network of protective genes. This new study further investigates Protandim’s ability to increase production of the body’s Nrf2-regulated protective genes, sometimes referred to as “survival genes”, which include most of the antioxidant enzymes.
The study, titled “Protandim attenuates intimal hyperplasia in human saphenous veins cultured ex vivo via a catalase-dependent pathway” by Binata Joddar, Rashmeet K. Reen, Michael S. Firstenberg, Saradhadevi Varadharaj, Joe M. McCord, Jay L. Zweier, and Keith J. Gooch is published in the journal Free Radical Biology and Medicine and may be found at the following link.
Chemopreventative Effects of Protandim® Examined Further in New Peer-Reviewed Study
Protandim’s ability to modulate relationship between superoxide dismutase and tumor suppressor p53 believed responsible for reduction of skin cancers in mice
A study, conducted by researchers at Louisiana State University, examined the biochemical mechanisms that underlie the ability of Protandim® to suppress tumors in mice. That ability was previously demonstrated by the authors in a study involving a mouse two-stage model of chemically-induced skin cancer. Protandim®, a patented dietary supplement comprised of five highly synergistic herbal ingredients, has been shown in earlier studies to activate the transcription factor Nrf2, a signal to the cell’s DNA to regulate a network of protective genes. This new study further investigates Protandim’s® ability to increase production of the body’s Nrf2-regulated protective genes, sometimes referred to as “survival genes”, specifically in regard to chemoprevention.
Click here to view the study.
New Peer Reviewed Study Concludes That Protandim® Improves Markers of Oxidative Stress and Fibrosis in Muscular Dystrophy Mice
The study, titled The Dietary Supplement Protandim® Decreases Plasma Osteopontin and Improves Markers of Oxidative Stress in Muscular Dystrophy Mdx Mice by M.M. Qureshi, W.C. McClure, N.L. Arevalo, R.E. Rabon, B. Mohr, S.K. Bose, J.M. McCord, and B.S. Tseng, documents a 48% decrease in plasma TBARS, a marker of lipid peroxidation and oxidative stress, a 57% decrease in plasma osteopontin, a fibrosis-promoting factor linked to heart failure, and a 35% increase in beneficial, protective plasma PON1 activity in those mice given Protandim® compared to those without Protandim. PON1 is an enzyme thought to protect against atherosclerosis by preventing the oxidation of low-density lipoprotein (LDL) cholesterol.
Click here to view the press release.
Prestigious American Heart Association Journal, Circulation, Publishes New Peer-Reviewed Study Involving Protandim®
Dr. Norbert Voelkel and researchers at Virginia Commonwealth University (VCU), demonstrated the ability of Protandim, the Company’s patented dietary supplement composed of five highly synergistic “indirect antioxidants”, to protect the heart in a laboratory model of pulmonary hypertension in rats. “We are encouraged by the results of this study, which was independently funded and independently conducted by Dr. Voelkel and his colleagues at VCU,” stated David Brown, President & CEO of LifeVantage.
“These results illustrate the unique antioxidant, anti-inflammatory, and anti-fibrotic properties of Protandim. Scientists have long known of the involvement of oxidative stress in disease processes, and this study is a significant example of how oxidative stress affects susceptibility to right heart failure in animals. Although it would be premature to conclude that similar benefits would be seen in humans, these remarkable results open the door to the possibility of future research on pulmonary hypertension and Protandim in humans.”
Click here to view the press release.
Synergistic induction of heme oxygenase-1 by the components of an antioxidant supplement Protandim, Free Radical Biology and Medicine (2008)
Results of a new peer-reviewed study (Free Radical Biology & Medicine, on November 18, 2008) clearly demonstrate that Protandim produces a 300 percent increase in glutathione, which is a key antioxidant and anti-aging factor. In addition, the study shows that Protandim’s synergistic formulation provides more antioxidant power than any food or conventional supplement.
Click here to view the study.
2009 Peer Reviewed Study from Louisiana State, PLoS ONE Journal.
Peer Reviewed Study from Louisiana State University, “Protandim®, a Fundamentally New Antioxidant Approach in Chemoprevention Using Mouse Two-Stage Skin Carcinogenesis as a Model,” Published in PLoS ONE Journal.
Click here to view the study.
PROTANDIM HAS BEEN ISSUED FOUR PATENTS AND HAS BEEN FEATURED ON ABC’s PRIMETIME.
This is a must-read article about a little independent clinical study that an osteopathic doctor in Nevada did on correcting nutritional deficiencies: https://www.explorepub.com/current-issue-203/499-adaptogen-complex-found-to-correct-nutritional-deficiencies.html
According to the article’s abstract, “This article discusses a small clinical study conducted by Daniel F. Royal, DO, HMD, JD on 10 patients who took an adaptogen complex, known as “Protandim” for three to six months. Each patient took a pre and post SpectraCell MicroNutrient Test. An analysis of the results revealed that the patients’ nutritional deficiencies were found to correct as a result of taking the product. These unexpected findings suggest that the body may create nutritional deficiencies when antioxidant levels are inadequate. A call to expand the study for the purpose of further evaluating whether individual antioxidant levels can be optimized, after nutritional deficiencies have been corrected, is proposed.”
Dr. David Perlmutter, a world renowned Board-Certified Neurologist, recommends Protandim® for his patients. Dr. Perlmutter has been interviewed on many nationally syndicated radio and television programs including 20/20, Larry King Live, CNN, Fox News, Fox and Friends, The Today Show, Oprah, Oprah and Friends, Oprah Radio with Dr. Oz, and The CBS Early Show. He was awarded the 2002 Linus Pauling Award for his pioneering work in innovative approaches to neurological disorders, and is the recipient of the 2006 National Nutritional Foods Association Clinician of the Year Award. He is involved in pioneering work in the use of Glutathione in fighting diseases such as Parkinson’s disease and Alzheimer’s. He has appeared on Oprah and Friends on April 3, 2009 with Dr. Oz to discuss new findings affecting Parkinson’s disease. Since Protandim was proven to raise Glutathione levels up to 300% in a peer-reviewed study published in November of 2008, the doctor treats his patients with Protandim.
Dr. Perlmutter states, “The health benefits of increased glutathione are numerous, because of its antioxidant and potential anti-aging activity factors. Protandim’s® effects on glutathione enhancement are tremendous, and as a neurologist, I am keenly interested in the impact of Protandim® on brain disorders as well as a variety of medical conditions and diseases.”
Distributor with LifeVantage
CALL ANYDAY, 9am to 9pm CENTRAL Time